Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study (Q42982910)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 June 2010
edit
Language Label Description Also known as
English
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
scientific article published on 3 June 2010

    Statements

    Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study (English)
    Stewart B Harris
    Jan Neuman
    Ravi R Retnakaran
    Janet Raboud
    3 June 2010
    9735
    103-111

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit